Yumi Mitsuya, MD

Associate Professor

UCSF Benioff Children's Hospital Oakland - Pediatric Physical Medicine and Rehabilitation - Physical Medicine and Rehabilitation

744 52nd Street
Oakland CA 94609

510-428-3655

Publications

Andrews JP, Ore CD, Falcone J, Hirschhorn M, Sagar C, Sigford K, Mitsuya Y, Chung T, Sun PP. Single-level laminoplasty approach to selective dorsal rhizotomy with conus localization by rapid spine MRI. Childs Nerv Syst. 2024 Aug; 40(8):2565-2571. PMID: 38797737
Su S, Mitsuya Y, Schirmer D, Levin J. Attempted aspiration of a symptomatic lumbar juxtafacet cyst resulting in improvement of acute onset radiculopathy with progressive motor weakness. Interv Pain Med. 2022 Jun; 1(2):100101. PMID: 39239377
Varghese V, Mitsuya Y, Fessel WJ, Liu TF, Melikian GL, Katzenstein DA, Schiffer CA, Holmes SP, Shafer RW. Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1. Antimicrob Agents Chemother. 2013 Sep; 57(9):4290-4299. PMID: 23796938
Varghese V, Mitsuya Y, Shahriar R, Bachmann MH, Fessel WJ, Kagan RM, Shafer RW. Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility. Antimicrob Agents Chemother. 2009 May; 53(5):2196-8. PMID: 19223644
Mitsuya Y, Varghese V, Wang C, Liu TF, Holmes SP, Jayakumar P, Gharizadeh B, Ronaghi M, Klein D, Fessel WJ, Shafer RW. Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations. J Virol. 2008 Nov; 82(21):10747-55. PMID: 18715933
Eriksson N, Pachter L, Mitsuya Y, Rhee SY, Wang C, Gharizadeh B, Ronaghi M, Shafer RW, Beerenwinkel N. Viral population estimation using pyrosequencing. PLoS Comput Biol. 2008 May 09; 4(4):e1000074. PMID: 18437230
Mitsuya Y, Liu TF, Rhee SY, Fessel WJ, Shafer RW. Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatment. J Infect Dis. 2007 Oct 15; 196(8):1177-9. PMID: 17955436
Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 2007 Aug; 17(8):1195-201. PMID: 17600086
Mitsuya Y, Winters MA, Fessel WJ, Rhee SY, Hurley L, Horberg M, Schiffer CA, Zolopa AR, Shafer RW. N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure. AIDS Res Hum Retroviruses. 2006 Dec; 22(12):1300-5. PMID: 17209774
Mitsuya Y, Winters MA, Fessel WJ, Rhee SY, Slome S, Flamm J, Horberg M, Hurley L, Klein D, Shafer RW. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL. J Acquir Immune Defic Syndr. 2006 Sep; 43(1):56-9. PMID: 16885777
Uneda S, Hata H, Matsuno F, Nagasaki A, Harada N, Mitsuya Y, Matsuzaki H, Mitsuya H. A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse model. Br J Haematol. 2003 Feb; 120(3):396-404. PMID: 12580953
Uneda S, Hata H, Matsuno F, Harada N, Mitsuya Y, Kawano F, Mitsuya H. Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. Br J Haematol. 2003 Jan; 120(1):53-5. PMID: 12492576

Education

Degree	Organization	Year
	M.D.	Albany Medical College
	Residency, Physical Medicine and Rehabilitation	Stanford University
	Residency, Pediatrics	UCSF Benioff Children's Hospital Oakland

Videos

Meet the Doctor: Yumi Mitsuya, MD

About Yumi Mitsuya, MD

Dr. Yumi Mitsuya, MD is Chief of Pediatric Physical Medicine & Rehabilitation at UCSF Benioff Children’s Hospital Oakland. Dr. Mitsuya specializes in the care of children with congenital and acquired disabilities, including spina bifida, cerebral palsy, neuromuscular disorders, and brain and spinal cord injuries, with a special interest in neurotrauma. Her expertise includes spasticity management with botulinum toxin chemodenervation and ethanol chemoneurolysis, as well as intrathecal baclofen pump therapy.

She earned her medical degree from Albany Medical College, completed her Pediatrics residency at UCSF Benioff Children’s Hospital Oakland, and her residency in Physical Medicine and Rehabilitation at Stanford University. Her research interests focus on advancing care for children with cerebral palsy, neurotrauma, and spinal disorders.

In addition to her clinical and research work, Dr. Mitsuya is actively involved in educating trainees and colleagues and in community outreach supporting children with complex rehabilitation needs.

Yumi Mitsuya, MD

Faculty

Yumi Mitsuya, MD

Yumi Mitsuya, MD

Publications

Education

Videos

About Yumi Mitsuya, MD

Related News